314.
Some improvement in the yield of the antibiotic was attained by supplementing the standard medium with two end-produtcs of metabolic pathways related to saframycin biosynthesis.
A further significant increase of saframycin A potency could be attained by addition of NaCN to the culture broth. Finally, a drastic degradation of saframycin A in the culture was successfully prevented by maintaining the pH lower than 5.5 after peak production of the antibiotic. The combined application of these improvements resulted in approximately 1,000-fold increase in saframycin A production as compared with the parental level.
The precursor of saframycin A in the culture, which yielded saframycin A upon cyanation was isolated, characterized and named saframycin S. Physicochemical properties of saframycin S were described and structural formulae were discussed.
Saframycins are satellite antibiotics which are co-produced in a trace quantity with streptothricin by Str•eptonryces lavendulae No. 314. The antibiotics are unique compounds which have a dimeric heterocyclic quinone skeleton in common. Among the saframycins, 5 components have been isolated and characterized to date and saframycin A has proved to be the most biologically active compound1).
The structure of saframycin C was first elucidated by X-ray crystallography and subsequent studies revealed that saframycin B is C-14 demethoxy saframycin C2). On the other hand, saframycin A has nitrite group at C-21 position of saframycin B3). They are active against a number of Gram-positive bacteria and their antitumor activity on EHRLICH ascites tumor, mouse leukemias L1210 and P388, B16 melanoma and human tumor xonografts in nude mice has also been described4,5). Studies on the mode of action of saframycin A have also revealed a novel role of the nitrile group in its interaction with DNA6).
The search for such satellite antibiotics among known species of streptomyces coupled with highly sensitive in vitro screening procedures, therefore, seems to hold out a fair chance of isolating unprecedented groups of antibiotics which are prone to be missed by the conventional screening procedures').
On the other hand, difficulty inheres in the development of such satellite antibiotics for chemotherapeutic agents because of their extremely low production in the culture of streptomyces. For example, the production of saframycins was as low as 0.01 mcg/ml of the culture filtrate in the initial stage of studies. The increased production of the antibiotics was attained to some extent by improving culture condition and medium ingredients. The way of circumventing the underlying obstacle, however, was found by the identification of the saframycin A precursor, saframycin S, and its subsequent cyanation to saframycin A. another satellite antibiotic, in addition to the saframycins. However, mimosamycin was almost inactive on Bacillus subtilis and its effect was negligible9). The concentration of saframycin A, determined by thin-layer chromatography, also increased rapidly, followed by a sudden decrease within 1 -2 hours. Exhaustion of carbon sources resulted in cessation of growth and beginning of autolysis of the culture with a subsequent pH increase. It follows from the above experimental results that not only the advance in saframycin potency in the culture broth but also the inhibition of the rapid rate of degradation of the formed antibiotic is necessary for increased antibiotic production, especially in a large-scale production. With the final aim to maintain a high level of saframycin A concentration during fermentation and the later extraction, we studied the stability of the antibiotic in a pH range between 1.0 and 8.0
in the presence and absence of resting cells of the producer strain. The results are presented in Table 3 and Fig. 6 . In the absence of resting cells saframycin A was fairly stable at pH below 7.0 and a decrease in activity was only observed at pH 8.0. On the contrary, in the presence of 10% resting cells significant degradation occurred already at pH-values over 4.0. As shown in Fig. 6 , the degradation was accompanied by the appearance of slow moving, less active substances. The regulation of pH of the culture after appearance of the production peak of saframycin A, which was reasonably estimated by purple coloration of the mycelia, was then attempted and the results are shown in Fig. 7 . In the control culture, saframycin A concentration tended to decrease rapidly after reaching the peak, while a prolonged maximum stationary phase appeared in the culture adjusted to a constant pH of 5.5.
A further protraction was attainable at pH 5.0 which would allow ample time for termination of the fermentation and for the extraction of the antibiotic. The improvement of medium ingredients and cultural conditions coupled with the potentiation with NaCN as described above resulted in an about 1000-fold increase in saframycin A production: The original concentration of 0.01 mcg/ml could be raised to a level of more than 10 mcg/ml. in a flask, fitted with a Liebig condenser, at 120°C for 40 minutes. Simultaneously, volatilized HCN gas was collected into 2 % NaOH solution. The reaction mixture was then carefully adjusted to pH 7.0 and extracted twice with equal amounts of ethyl acetate. The solvent layer was dried and the purification of the antibiotic was performed as described above; 228 mg of the antibiotic were obtained in a yield of 40.5 % and its identity with saframycin S was confirmed by thin-layer chromatography and other physico-chemical properties. The proton magnetic resonance spectrum of saframycin S is shown in Fig. 10 ; PMR (6, CDCl3, 100 Mz): 1.94 (3H, s, -&=L-CH3), 2.06 (3H, s, -L=L-CH3), 2.30 (3H, s, -CO-CH3), 2.52 (3H, s, -N-CH3), 4.06 (3H, s, -C=C-OCH3). Saframycin S was soluble in lower alcohols, chloroform, ethyl acetate, acetone and ether, and insoluble in water. The antibiotic gave a positive reaction with DRAGENDORFF reagent. The UV spectrum of saframycin S is identical with that of saframycin A. In the PMR spectrum of saframycin S are shown six methyl groups as in the spectrum of saframycin A. Thus, the basic skeleton of saframycin S is assumed to be identical with that of saframycin A.
On the other hand, an absorption ascribed to hydroxy group (VCHC13OH 3400 cm-1) in the IR spectrum of saframycin S, was not observed in the spectrum of saframycin A. The carbon magnetic resonance spectra of saframycins A and S are shown in Table 4 . The signals at 8 116.7 (s) and 6 58. 3 (d) of saframycin A disappeared with saframycin S, while a new signal appeared at S 81.6 in doublet.
Although the signal at 33 81.6 (d) was in a field too low for the carbon substituted hydroxy group, it was logically assigned for the carbon in a-carbinolamine form. Consequently, the structure of saframycin S is reasonably explained in that the C-21 cyano group of saframycin A is substituted with a hydroxy group.
Furthermore, the reaction product of saframycin S and NaCN in neutral or acidic solution was identified as saframycin A by TLC, using several solvent systems, and by the mass, CMR, and IR spectra. These experimental results are also in support of the C-21 hydroxy substituted a-carbinol- 
